Similarly, pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist [64], and low-dose aspirin [53] significantly reduced pro-inflammatory cytokines, with aspirin mitigating cancer-induced cognitive impairment by targeting tumor-derived inflammatory signaling. The gene discussed is PPARG; the disease is cancer.